LivaNova PLC
LIVN
Rank in Stocks
#3864
LivaNova PLC is a global medical technology company dedicated to developing,... LivaNova PLC is a global medical technology company dedicated to developing, manufacturing, and marketing a variety of therapeutic solutions. The company operates through three key segments. Its Cardiopulmonary division provides essential products for heart-lung procedures, such as oxygenators, heart-lung machines, and various perfusion systems. The Neuromodulation segment is known for its VNS Therapy System, an implantable device that delivers vagus nerve stimulation to treat drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. This segment is also advancing the VITARIA System, which employs VNS for heart failure, through clinical development. The Advanced Circulatory Support segment offers temporary life support solutions, including both cardiopulmonary and respiratory support technologies. LivaNova serves a wide range of medical professionals, including perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals and healthcare providers. The company's products are distributed globally through both its direct sales force and independent distributors. Additionally, LivaNova has a research collaboration with Verily aimed at discovering clinical biomarkers for depression. Founded in 1987, the company is headquartered in London, United Kingdom.
Share Price
$77.72
Last synced: 2026-10-16
Market Cap
$4.27B
Change (1 day)
-0.99%
Change (1 year)
44.65%
Country
GB
Trade LivaNova PLC (LIVN)
Category
Healthcare
Operating Margin for LivaNova PLC (LIVN)
Operating Margin as of October 2026 TTM: 13.48%
According to LivaNova PLC latest financial reports and stock price the company's current Operating Margin (TTM) is 13.48%. At the end of 2023 the company had an Operating Margin of -5.94%.
Operating Margin history for LivaNova PLC from 2000 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 13.48% | 30.87% |
| 2024 | 10.30% | -273.40% |
| 2023 | -5.94% | -215.12% |
| 2022 | 5.16% | -5,833.33% |
| 2021 | -0.09% | -98.03% |
| 2020 | -4.58% | -203.39% |
| 2019 | 4.43% | -119.77% |
| 2018 | -22.41% | -337.14% |
| 2017 | 9.45% | -516.30% |
| 2016 | -2.27% | -107.46% |
| 2015 | 30.41% | -1.30% |
| 2013 | 30.81% | 10.47% |
| 2012 | 27.89% | 7.98% |
| 2011 | 25.83% | 17.57% |
| 2010 | 21.97% | 66.19% |
| 2009 | 13.22% | -294.70% |
| 2008 | -6.79% | -82.05% |
| 2007 | -37.82% | -21.18% |
| 2006 | -47.98% | 284.46% |
| 2005 | -12.48% | -306.28% |
| 2004 | 6.05% | 35.04% |
| 2003 | 4.48% | -111.54% |
| 2002 | -38.81% | 0.00% |
| 2001 | 0.00% | -100.00% |
| 2000 | -10.97% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 17.03% | -98.74% |
US
|
|
| 17.86% | -98.68% |
IE
|
|
| 22.03% | -98.37% |
US
|
|
| 21.46% | -98.41% |
US
|
|
| 0.00% | - |
DE
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.